Cadence Bancorp (NYSE:CADE) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.74 by 5.41 percent. This is a 16.42 percent increase over earnings of $0.67 per share from the same period last year.
BTIG Maintains Buy on Axsome Therapeutics, Raises Price Target to $98
BTIG analyst Robert Hazlett maintains Axsome Therapeutics (NASDAQ:AXSM) with a Buy and raises the price target from $62 to $98.